Castaman, G., Coppola, A., Zanon, E., Boeri, E., Musso, M., Siragusa, S., et al. (2012). Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. HAEMOPHILIA, vol. 7, p. 1-7.

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease

MUSSO, Mariarita;SIRAGUSA, Sergio;MANCUSO, Gaetano;
2012-01-01

2012
Settore MED/15 - Malattie Del Sangue
Castaman, G., Coppola, A., Zanon, E., Boeri, E., Musso, M., Siragusa, S., et al. (2012). Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. HAEMOPHILIA, vol. 7, p. 1-7.
File in questo prodotto:
File Dimensione Formato  
WISH Prosp-Haemophilia 2012.pdf

accesso aperto

Dimensione 105.19 kB
Formato Adobe PDF
105.19 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/75401
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 21
social impact